Congress demands info from period tracking apps and data brokers, including policies on geofencing, as part of an investigation into reproductive health data
Context & Ripple Effects
The investigation lands weeks after Roe's reversal, when privacy advocates first warned that period tracking apps may be sharing cycle data with partners or affiliates where it could become evidence of a crime. The concern has a longer paper trail: Privacy International documented apps like MIA Fem and Maya transmitting monthly timings, contraception use, and symptoms to Facebook back in 2019 years before abortion became a legal risk.
By demanding geofencing policies specifically, Congress is targeting the mechanism behind the location-data side of the story — the same capability that led SafeGraph to stop selling visits to Planned Parenthood in May, and that Tapestri later said two companies tried to buy for identifying clinic visitors once the draft ruling leaked.
First-order effects
- The period tracking apps and data brokers receiving the inquiry must now disclose their geofencing and data-sharing policies on the record, exposing practices like the Facebook transmissions Privacy International flagged.
Second-order effects
- Brokers face a choice between disclosure and exit: SafeGraph already chose withdrawal from clinic-location sales, and Tapestri's account of two prospective buyers shows demand exists but now carries reputational and legal exposure.
- The inquiry hands enforcement ammunition to regulators — within weeks the FTC sued Kochava for selling data revealing reproductive health clinic visits, converting congressional attention into an actual enforcement case.
Third-order effects
- If the pattern holds, reproductive health data becomes a de facto regulated category: brokers self-censor sensitive locations and app makers restructure sharing not because of new law, but because disclosure requests and FTC suits make the status quo untenable.
- The geofencing focus signals that Congress sees precise location as the core liability in the adtech supply chain, putting every broker that resells movement data — not just health-focused ones — under the same investigative template.
The trend: After Roe's reversal, reproductive health data is turning into a legally hazardous asset class, pushing location brokers and tracking apps toward voluntary withdrawal or enforced disclosure.